Research Team

Program Announcement:

  • Purpose. The purpose of the CFO Research Team Program is to provide initial support for the formation of strong investigative teams within the Organogenesis community. It is expected that research teams receiving seed support under this program will be well positioned to compete for externally-funded multi-investigator grants such as NIH P01s.
  • Budget and Project Period. Budgets for direct costs of up to $150,000 per year with a project duration of up to three years may be requested. Indirect costs are not supported. Faculty salary costs are not allowed; departmental cost sharing for faculty effort is required.
  • Anticipated Number of Awards. It is anticipated that 1-3 projects will be funded.  The total amount awarded and the number of awards will vary depending upon the number of applications, their merit, duration, and proposed costs.
  • Eligible Investigators. Groups of 3 or more investigators are eligible.  Each investigator in the team should have an independent research program and hold the title of Assistant, Associate or Professor in the instructional or research faculty track.  The Program Director must be a member of the Center for Organogenesis.
  • Permanent Funding Plan. Proposals must include a plan for application for external funding, and funded groups will be required to submit a multi-investigator grant proposal, such as an NIH P01, during the course of the funding.
  • Review Process. Letters of intent will be reviewed to identify teams with appropriate and competitive projects for submission of a full proposal.

The Center for Organogenesis seeks to promote research in science and engineering to understand the basic mechanisms by which organs and tissues are formed and maintained, and to use this knowledge to create artificial organs, stem cell therapies or organ transplantation systems and other novel approaches to treat genetic and acquired diseases. The Center for Organogenesis is especially interested in supporting projects that include translational components that could lead to the development of drugs, devices or artificial organs for the treatment of human disease. However, the Center also seeks to balance its research funding between “basic” and “translational” science to yield fundamental new insights in the field of Organogenesis. The following research focus areas have been defined:

  1. Organ Development
  2. Organ/Tissue Maintenance and Replacement
  3. Abnormal Organ Growth, including Cancer

Deadlines for the fourth round of funding*

Letters of intent:          February 15, 2013

Full proposals:            March 25, 2013

Information:

Inquiries about the program should be directed to Linda Samuelson (lcsam; 764-9448), Chair of the CFO Research Team Committee.  Questions about the submission process should be directed to Becky Pintar (rpintar; 936-2499).